- Report
- June 2020
- 222 Pages
From €2888EUR$3,159USD£2,585GBP
€3610EUR$3,949USD£3,231GBP
- Drug Pipelines
- May 2020
- 1460 Pages
From €2286EUR$2,500USD£2,045GBP
From €997EUR$1,090USD£892GBP
From €3648EUR$3,990USD£3,265GBP
- Report
- March 2020
- 120 Pages
From €2286EUR$2,500USD£2,045GBP
- Drug Pipelines
- February 2020
- 106 Pages
From €2286EUR$2,500USD£2,045GBP
- Drug Pipelines
- December 2019
- 1380 Pages
From €1829EUR$2,000USD£1,636GBP
- Report
- December 2019
- 200 Pages
From €3657EUR$4,000USD£3,273GBP
From €1618EUR$1,770USD£1,448GBP
From €2935EUR$3,210USD£2,626GBP
- Report
- July 2020
- 86 Pages
From €1325EUR$1,449USD£1,186GBP
- Report
- May 2020
- 85 Pages
From €1646EUR$1,800USD£1,473GBP
- Report
- May 2020
- 89 Pages
From €1646EUR$1,800USD£1,473GBP
- Report
- May 2020
- 225 Pages
From €3657EUR$4,000USD£3,273GBP
- Report
- January 2019
- 188 Pages
From €3840EUR$4,200USD£3,436GBP
- Report
- December 2018
- 83 Pages
From €5440EUR$5,950USD£4,868GBP
- Drug Pipelines
- June 2017
- 77 Pages
From €4526EUR$4,950USD£4,050GBP
- Drug Pipelines
- June 2017
- 60 Pages
From €2240EUR$2,450USD£2,005GBP
- Drug Pipelines
- June 2014
- 165 Pages
From €1646EUR$1,800USD£1,473GBP
- Report
- July 2020
- 2006 Pages
€3520EUR$3,850USD£3,150GBP
Cervical cancer is the second most common and the fifth most deadly cancer in women. Approximately 80% of cervical cancers occur in developing countries which makes emerging economies such as China a major target market for pharmaceutical companies in the cervical cancer sector. The following expert reports enable buyers to examine the essential issues: supply and demand, forecasts, drug development and discovery, licensing, SWOT analyses, key industry players and more. This is the place for the inside track on market entry opportunities, growth strategies, buyer solutions and potential industry alliances in the area of cervical cancer drug development. Show Less Read more
